# KeySine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/keysine

- Industry: Healthcare
- Headquarters: Jinan, China
- Latest round: Series A (Apr 18, 2025)
- Investors on record: 2

## About

Established in 2021 and based in Jinan, China, KeySine is a reproductive health service company. In April 2025, it closed a series A+ funding co-led by new investors YR Delta Investment Management and Jinan International Medical Center Industrial Development Co., Ltd.

The company’s main business is addressing unmet clinical needs in reproductive health through innovative medical solutions. The company’s self-developed product portfolio includes tubal interventional therapy systems, uterine infertility treatment devices, and ovarian function restoration technologies. Its products are used in the field of reproductive medicine.

KeySine generates revenue by providing advanced medical devices, tailored clinical solutions, and technology licensing partnerships to healthcare institutions.

The company will use the series A+ funding to build a complex industrial center that integrates production, marketing, and industry-university-research cooperation, and to accelerate the implementation of product pipelines to provide solutions for infertility treatment.

## Funding rounds

- Series A, Apr 18, 2025 — YR Delta Investment Management, Jinan International Medical Center Industrial Development Co., Ltd

## Investors

- YR Delta Investment Management (https://capitalatlas.ai/funds/yr-delta-investment-management) — Series A
- Jinan International Medical Center Industrial Development Co., Ltd — Series A